Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Abraxane

Generic name: Paclitaxel

FDA application holder: Bristol-Myers

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Abraxane?
Abraxane is a brand name of Paclitaxel, a prescription medicine. The FDA NDC Directory lists 1 Abraxane product in 1 strength and form.
Who makes Abraxane?
Bristol-Myers holds the FDA application for Abraxane (NDA021660, approved January 7, 2005).
Is there a generic or store brand of Abraxane?
Yes. The FDA NDC Directory lists 9 other products with the same active ingredients, strength and form as a Abraxane product, 7 of them generic. Ask your pharmacist whether one is right for you.
Has Abraxane been recalled?
No recall linked to Abraxane products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Abraxane is

Each Abraxane product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Paclitaxel · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
paclitaxel 100 mg/20 mL
injection, powder, lyophilized, for suspension (intravenous)
Abraxane 9 products, 9 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Paclitaxel →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Abraxane products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA021660Bristol-MyersJanuary 7, 20051

Companies that list Abraxane

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Abraxane products.

Recalls

No recall linked to Abraxane products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers